What's the Span Divergent share price today?

Span Divergent share price is Rs 38.50 as on 15 Jun, 2026, 04:01 PM IST. Span Divergent share price is remain unchanged by N.A. based on previous share price of Rs. 38.5.

What is the PE & PB ratio of Span Divergent ?

The PE ratio of Span Divergent stands at -12.91, while the PB ratio is 2.85.

What is 52 week high/low of Span Divergent share price?

In last 52 weeks Span Divergent share had a high price of Rs 45.30 and low price of Rs 8.66

What's the market capitalization of Span Divergent ?

Market Capitalization of Span Divergent stock is Rs 27.96 Cr.

Span Divergent Share Price

38.50

BSE

Closed
As On:
As On: 15 Jun, 2026, 04:01 PM IST

Sector: Hospitals & All...
Industry: Medical Equipment ...

STOCK SCORE

Unlock Scores

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	-
High	-
Low	-
Prev Close	-
Volume	-
VWAP(₹)	-

Share Price	Value
Today/Current/Last	-38.50
Previous Day	-38.50

Span Divergent Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcements
Board Meeting Intimation for Span Divergent Limited Board Meeting To Be Held On May 3..
Announcements
Span Divergent Limited - Intimation Of Change In Name Of Subsidiary LLP Pursuant To R..
Announcements
Span Divergent Limited - Disclosure Under Regulation 30 Of The Securities And Exchang..
Announcements

View all Span Divergent Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	4.07	7.86	1.79	0.88	2.33
Total Income Growth (%)	-48.29	338.74	102.70	-61.99	233.06
Total Expenses	5.09	7.91	1.82	1.72	2.36
Total Expenses Growth (%)	-35.68	335.14	5.37	-26.88	423.29
EBIT	-1.02	-0.05	-0.03	-0.84	-0.03
EBIT Growth (%)	-	-	-	-	-113.29
Profit after Tax (PAT)	-0.97	-0.13	-0.10	-0.89	-0.15
PAT Growth (%)	-	-	-	-	-163.01
EBIT Margin (%)	-25.12	-0.59	-1.42	-95.09	-1.41
Net Profit Margin (%)	-23.93	-1.71	-5.49	-100.21	-6.55
Basic EPS (₹)	-2.08	-0.34	-0.31	-1.87	-0.39

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	0.54	0.56	0.65	0.68	0.64
Total Income Growth (%)	-3.78	-14.00	-5.02	6.08	-7.73
Total Expenses	0.39	0.44	0.22	0.54	0.39
Total Expenses Growth (%)	-12.07	99.77	-59.04	39.71	-13.98
EBIT	0.15	0.12	0.43	0.14	0.26
EBIT Growth (%)	28.15	-73.07	201.41	-44.74	3.63
Profit after Tax (PAT)	0.14	0.12	0.42	0.13	0.23
PAT Growth (%)	14.40	-71.18	215.68	-43.81	-2.81
EBIT Margin (%)	27.45	20.61	65.82	20.74	39.82
Net Profit Margin (%)	25.57	21.51	64.18	19.31	36.45
Basic EPS (₹)	0.25	0.22	0.76	0.24	0.43

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	10.15	14.35	13.18	14.73	9.33
Total Revenue Growth (%)	-29.28	8.86	-10.52	57.81	-21.38
Total Expenses	11.29	13.64	14.59	15.93	14.33
Total Expenses Growth (%)	-17.22	-6.57	-8.35	11.12	-30.43
Profit after Tax (PAT)	-0.92	0.98	-5.05	-9.80	-5.59
PAT Growth (%)	-194.02	-	-	-	-
Operating Profit Margin (%)	-5.98	11.61	-3.30	-0.87	-46.18
Net Profit Margin (%)	-10.23	7.91	-40.35	-74.87	-75.46
Basic EPS (₹)	-2.33	1.43	-9.93	-18.59	-11.28

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	2.76	3.46	2.70	3.12	3.21
Total Revenue Growth (%)	-20.28	28.53	-13.56	-2.75	0.34
Total Expenses	1.84	2.04	1.88	2.02	2.07
Total Expenses Growth (%)	-9.69	7.98	-6.62	-2.67	-34.22
Profit after Tax (PAT)	0.84	1.51	-3.34	-7.76	0.00
PAT Growth (%)	-44.39	-	-	-	-
Operating Profit Margin (%)	57.38	74.65	41.38	56.00	80.31
Net Profit Margin (%)	52.15	78.86	-170.36	-394.96	-0.12
Basic EPS (₹)	1.54	2.76	-6.11	-14.20	0.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 82.4% outperformed its 3 year CAGR of 11.86%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 2.51% of its operating revenues towards interest expenses and 12.46% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	23.20	24.19	25.59	27.83	34.44
Total Assets Growth (%)	-4.07	-5.49	-8.03	-19.20	-12.96
Total Liabilities	32.04	31.75	33.95	30.76	27.22
Total Liabilities Growth (%)	0.91	-6.47	10.38	13.00	3.86
Total Equity	-8.84	-7.57	-8.36	-2.93	7.22
Total Equity Growth (%)	-	-	-	-140.62	-45.96
Current Ratio (x)	0.46	0.46	0.42	0.52	1.15
Total Debt to Equity (x)	-2.87	-4.55	-3.50	5.08	1.48
Contingent Liabilities	4.68	4.03	4.03	15.38	15.38

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	39.96	38.46	37.64	40.87	49.85
Total Assets Growth (%)	3.90	2.18	-7.90	-18.01	0.89
Total Liabilities	5.20	4.34	5.02	4.90	6.12
Total Liabilities Growth (%)	19.82	-13.55	2.45	-19.93	7.75
Total Equity	34.75	34.12	32.62	35.97	43.73
Total Equity Growth (%)	1.85	4.60	-9.31	-17.75	0.02
Current Ratio (x)	3.17	3.24	2.49	2.93	4.60
Total Debt to Equity (x)	0.06	0.06	0.08	0.07	0.07
Contingent Liabilities	4.68	4.03	4.03	14.58	14.58

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	1.86	2.50	1.98	7.03	-0.21
Net Cash used in Investing Activities	-1.05	0.12	0.53	-2.05	1.99
Net Cash flow from Financing Activities	-1.15	-2.09	-2.30	-5.50	-1.41
Net Cash Flow	-0.34	0.53	0.20	-0.52	0.37
Closing Cash & Cash Equivalent	0.59	0.93	0.40	0.19	0.71
Closing Cash & Cash Equivalent Growth (%)	-36.73	131.85	105.56	-72.76	106.96
Total Debt/ CFO (x)	4.33	3.43	5.03	1.60	-83.71

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	1.00	0.53	0.58	-0.31	0.37
Net Cash used in Investing Activities	-1.10	0.16	-0.36	0.43	-0.57
Net Cash flow from Financing Activities	0.15	-0.56	-0.02	-0.20	0.30
Net Cash Flow	0.04	0.13	0.20	-0.08	0.10
Closing Cash & Cash Equivalent	0.42	0.38	0.25	0.05	0.13
Closing Cash & Cash Equivalent Growth (%)	11.33	51.18	440.91	-63.69	302.70
Total Debt/ CFO (x)	1.92	3.72	4.36	-8.35	8.45

All figures in Rs Cr, unless mentioned otherwise

View Details

Ratios

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	0.00	-51.69	0.00	-441.28	-46.47
Return on Capital Employed (%)	11.42	-50.78	18.32	-2.42	-16.77
Return on Assets (%)	-3.95	4.03	-19.75	-35.21	-16.22
Interest Coverage Ratio (x)	0.91	4.28	1.75	1.90	-0.20
Asset Turnover Ratio (x)	0.38	0.50	0.47	0.42	0.03
Price to Earnings (x)	-17.12	9.58	-1.44	-0.69	-1.24
Price to Book (x)	-5.59	-4.95	-2.56	3.03	0.57
EV/EBITDA (x)	30.18	3.68	6.44	6.08	-60.96
EBITDA Margin (%)	6.15	24.95	14.00	15.68	-4.21

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	2.41	4.42	-10.23	-21.56	0.00
Return on Capital Employed (%)	2.44	3.90	2.28	2.81	2.46
Return on Assets (%)	2.10	3.92	-8.86	-18.98	0.00
Interest Coverage Ratio (x)	0.00	0.00	0.00	0.00	50.25
Asset Turnover Ratio (x)	0.04	0.05	0.05	0.04	0.03
Price to Earnings (x)	18.69	6.19	-2.18	-0.87	-5,000.00
Price to Book (x)	0.45	0.27	0.22	0.19	0.16
EV/EBITDA (x)	14.62	6.18	7.62	5.60	5.45
EBITDA Margin (%)	73.01	92.46	63.05	81.92	125.07

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Span Divergent	-12.91	2.85	-16.83	-21.51	-8.65	11.86	-14.35	-17.11	-5.38	1.10	0.48	33.00
Nureca Ltd	109.28	1.26	1.15	3.43	1.06	9.30	4.26	1.41	2.11	8.32	0.00	0.22
Denis Chem Lab	12.29	1.13	9.18	13.67	6.73	4.34	7.00	4.62	6.06	2.70	0.05	1.01
Constronics Infra	20.19	1.37	6.78	6.78	4.27	284.65	7.91	5.80	2.25	3.32	0.41	4.86
Bandaram Pharma Pack	154.57	1.70	1.05	4.68	0.37	48.68	3.09	0.44	0.83	1.66	0.89	-4.86
Add More

Annual Ratios (%)

Choose from Peers

Shree Pacetronix
Kretto Syscon
GKB Ophthalmics
Centenial Surg
Transgene Biotek

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Span Divergent Stock Performance	0.00	0.00	0.00	0.00	67.76	126.47	196.15
Nureca Ltd Stock Performance	-0.06	-11.55	-8.34	-18.15	-4.92	-27.91	-84.92
Denis Chem Lab Stock Performance	0.33	-0.94	-5.47	-6.53	-27.85	-4.04	32.90
Constronics Infra Stock Performance	1.20	-6.48	-15.03	-8.88	-17.32	0.00	0.00
Bandaram Pharma Pack Stock Performance	5.17	2.66	2.59	0.13	-19.76	0.00	0.00
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	34,95,700	48.13 %	-15.86
Pledge	0	0.00 %	0.00
Others	37,67,528	51.87 %	15.86

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	48.13	64.00	64.00	64.00
Pledge	0.00	0.00	0.00	0.00
FII	0.00	0.00	0.00	0.00
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	51.87	36.00	36.00	36.00

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Audited Results, Dividend & A.G.M.
May 25, 2026
Board Meeting
Quarterly Results
Feb 05, 2026
General Meeting
-
Jan 27, 2026

Board Meetings

Announced on	Meeting on
May 25, 2026	May 30, 2026
Audited Results, Dividend & A.G.M.
Feb 05, 2026	Feb 10, 2026
Quarterly Results
Jan 20, 2026	Jan 23, 2026
Preferential issue of shares
Dec 24, 2025	Dec 29, 2025
Others
Nov 03, 2025	Nov 10, 2025
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 15, 2013 Jul 16, 2013 5%
May 20, 2011 Jul 26, 2011 10%
Jun 07, 2010 Jun 18, 2010 25%
Jun 30, 2008 Aug 08, 2008 20%
Jun 25, 2007 Aug 10, 2007 18%
Bonus
Announced on Ex-Date
Jun 05, 2010 Jul 27, 2010
Bonus Ratio: 1 share(s) for every 1 shares held
Splits
No Data Available
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Jan 27, 2026 Feb 20, 2026
-
Jan 02, 2026 Feb 06, 2026
-
May 16, 2025 Sep 29, 2025
-
May 16, 2025 Sep 20, 2025
-
May 16, 2024 Sep 26, 2024
-

Announced on	Ex-Date	Dividend%
May 15, 2013	Jul 16, 2013	5%
May 20, 2011	Jul 26, 2011	10%
Jun 07, 2010	Jun 18, 2010	25%
Jun 30, 2008	Aug 08, 2008	20%
Jun 25, 2007	Aug 10, 2007	18%

Announced on	Ex-Date
Jun 05, 2010	Jul 27, 2010
Bonus Ratio: 1 share(s) for every 1 shares held

Announced on	Meeting on
Jan 27, 2026	Feb 20, 2026
-
Jan 02, 2026	Feb 06, 2026
-
May 16, 2025	Sep 29, 2025
-
May 16, 2025	Sep 20, 2025
-
May 16, 2024	Sep 26, 2024
-

About Span Divergent

Span Divergent Ltd., incorporated in the year 1980, is a Small Cap company (having a market cap of Rs 27.96 Crore) operating in Hospitals & Allied Services sector.

Span Divergent Ltd. key Products/Revenue Segments include Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 4.79 Crore, up 17.84 % from last quarter Total Income of Rs 4.07 Crore and up 441.87 % from last year same quarter Total Income of Rs .88 Crore. Company has reported net profit after tax of Rs -1.12 Crore in latest quarter.

The company’s top management includes Mr.Rajendra Chokhawala, Mr.Viral P Desai, Mr.Paras Desai, Dr.Pradip K Desai, Mr.Sanjay N Mehta, Dr.Shefali Desai, Mr.Jignesh Desai, Mr.Nirav Jogani, Ms.Urvi Shinde. Company has Y B Desai & Associates. as its auditors. As on 31-03-2026, the company has a total of .73 Crore shares outstanding.

Span Divergent Share Price Today is Rs. 38.5. On previous day, the Span Divergent Share Price (NSE) closed at Rs. 38.5, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 48.13% of the stake in Span Divergent shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Span Divergent stocks was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in Span Divergent shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Span Divergent stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Span Divergent Dividend: Ever since 1980, Span Divergent dividends has been paid out around 13 times. As on 15 Jun, 2026, 04:01 PM IST, The overall dividend yield for Span Divergent stands at 0.0%. The last dividend paid was on null (Rs. null). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. -2.98.

Span Divergent Bonus: The most recent bonus issue had been in year July 27, 2010 around 15 years ago at 1 : 1 ratio. The first bonus issue was announced in Jun 2010.

Stock Forecast:
After showing 4.79 Cr. of sales and 17.84% of quarterly net profit, there have been multiple ups and downs in the Span Divergent stock prices in the past few weeks. For example, Span Divergent stock price on 10th of June 2026 was around Rs. 38.5. Span Divergent share price now stands at an average of Rs. 38.5. Judging by last week's performance, stock is in down trend.

Span Divergent has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Span Divergent share.

Historical Prices and Performance:
Span Divergent,incorporated in 1980 is a Small Cap company (with a market cap of Rs. 27.96) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Span Divergent stock was -16.83%, 0.0%, -51.69%, 0.0% and -441.28% respectively.
The Span Divergent share gave a 3 year return of 129.17% as compared to Nifty 50 which gave a return of 27.64%.
Span Divergent announced 0.0% final dividend on null.

Key Metrics:
PE Ratio of Span Divergent is -12.91
Prices/Sales Ratio of Span Divergent is 1.47
Price/Book Ratio of Span Divergent is 2.85

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at -12.91 and 2.85 respectively.

Leadership of Span Divergent :
Urvi Shinde is Co. Secretary & Compl. Officer
Rajendra Chokhawala is Chairman & Director
Viral P Desai is Managing Director
Paras Desai is WholeTime Director & CFO
Shefali Desai is Non Independent Director
Sanjay N Mehta is Non Independent Director
Pradip K Desai is Non Independent Director
Jignesh Desai is Independent Director
Nirav Jogani is Independent Director

Industry

Medical Equipment & Accessories

Key Indices Listed On

-

Address

9th Floor,902 - 904, Rajhans Bonista,Surat, Gujarat - 395007

Contact

secretarial@span.co.in

http://www.span.in

PE Ratio(x)	-12.91
EPS - TTM(₹)	-2.98
MCap(₹ Cr.)	27.96
MCap Rank	-
PB Ratio(x)	-
Div Yield(%)	-
Face Value(₹)	-
52W High(₹)	45.30
52W Low(₹)	8.66
MCap/Sales	-
Beta(1 Month)	-
BV/Share(₹)	-

1 Day	0.0%
1 Month	4.99%
3 Months	N.A.
1 Year	N.A.
3 Years	N.A.
5 Years	142.44%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Span Divergent Share Price

Key Metrics